Showing results (141-150 of 385) with videos related to
Sort By:
Pageof 39
Prostate Cancer and Prostatic Diseases|December 16, 2017
Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillanceDavid E Guy, Avi Vandersluis, Laurence H Klotz, et al.European Urology Oncology|May 19, 2019
Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and EnzalutamideChristopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, et al.The Journal of Urology|March 23, 2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitorsDean Sol Elterman, Nathan Lawrentschuk, Emma Guns, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomyPaul Toren, Shabbir M H Alibhai, Andre Matthew, et al.European Urology|September 9, 2015
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and OutcomesJakub Dobruch, Siamak Daneshmand, Margit Fisch, et al.European Urology|July 7, 2009
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategyBas W G van Rhijn, Maximilian Burger, Yair Lotan, et al.Journal of the National Cancer Institute|October 20, 2005
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidityShabbir M H Alibhai, Marc Leach, George Tomlinson, et al.Journal of the National Cancer Institute|July 16, 2013
Association between metformin use and risk of prostate cancer and its gradeDavid Margel, David Urbach, Lorraine L Lipscombe, et al.Journal of Cancer Research and Clinical Oncology|January 16, 2007
MYH mutations are rare in prostate cancerEyun-Jung Shin, Edward Chappell, Vaijayanti Pethe, et al.Urologic Oncology|February 19, 2018
Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancerTarik Benidir, Karen Hersey, Antonio Finelli, et al.Pageof 39